Delivery Order SPE2DB20D7066-SPE2DB25FC1ZA
Award Date
1/6/25
Potential Completion Date
1/7/25
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,368.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML Infusion Bottles (100 ML) and does not have a set-aside designation.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,307.00 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML intravenous infusion bottles, 100 mL in size. The contract has an ultimate completion date of September 3, 2024.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,800.00 firm fixed-price contract is for the delivery of Omnipaque 240 mg/ml vials, a medical product used in healthcare settings. The award is not designated as a set-aside contract.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.50 firm fixed-price contract is for the delivery of OMNIPAQUE 300 MG/ML PLUSPAK 500ML, a medical product used in healthcare settings. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. This delivery order is part of a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,322.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML intravenous infusion bottles (100 mL). The award is not designated as a set-aside contract.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award is for the delivery of Omnipaque 350 mg/ml infusion bottles to the Defense Logistics Agency (DLA). The $1,625.20 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company, Cencora, Inc. The contract has no set-aside designation, indicating open competition.
Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Omnipaque 350 mg/mL infusion bottles (100 mL). The contract has a ceiling value of $4,948.92 and a completion date of July 18, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, potentially valued up to $999,999,999 through December 2025, for providing a comprehensive...
This federal contract award, valued at $1,218.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Omnipaque 350 mg/ml infusion bottles, a critical pharmaceutical product.
The award is a delivery order placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,164.10 firm fixed-price delivery order is for the procurement of Omnipaque 240 mg/ml vials, a contrast agent used in medical imaging procedures. The contract has a period of performance through July 15, 2024 and was awarded on July 12, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award, valued at $10,052.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Omnipaque 350 mg/ml infusion bottles (100 ml) and has a completion date of September 19, 2023. This is a firm-fixed-price delivery order contract, with no set-aside designation, indicating open competition.
Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider,...